Literature DB >> 8902200

Potentiation of GLP-1 insulinotropic action by a nonglucidic nutrient in the pancreas of diabetic GK rats.

V Leclercq-Meyer1, W J Malaisse.   

Abstract

Glucagon-like peptide 1 (GLP-1) is often referred to as a glucose-dependent insulinotropic agent and is currently under investigation as a tool in the treatment of noninsulin-dependent diabetes. This report shows that, in the absence of glucose, a nonglucidic nutrient, namely succinic acid dimethyl ester (SAD), allows full expression of the insulinotropic potential of GLP-1 in the perfused pancreas from diabetic GK rats. Thus, whereas the insulin and glucagon responses to GLP-1 in GK rats differ from those previously documented in nondiabetic animals when tested in the absence of exogenous nutrient, the secretory response of the endocrine pancreas to GLP-1 is virtually normalized in the GK rats when SAD is incorporated into the perfusate. It is proposed, therefore, that nonglucidic nutrients, such as SAD, may optimalize the B-cell secretory response to GLP-1 in noninsulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902200     DOI: 10.1006/bmme.1996.0070

Source DB:  PubMed          Journal:  Biochem Mol Med        ISSN: 1077-3150


  3 in total

Review 1.  Regulation, perturbation, and correction of metabolic events in pancreatic islets.

Authors:  W J Malaisse
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of L-glutamic acid in a type 2 diabetes animal model.

Authors:  J Cancelas; M L Villanueva-Peñacarrillo; I Valverde; W J Malaisse
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

3.  Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid.

Authors:  J Cancelas; M L Villanueva-Peñacarrillo; I Valverde; W J Malaisse
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.